Clinical Trial Update: Assessing DCog Short for Neurotoxicity in CAR-T [NA]

View source ↗

Summary

A clinical trial update describes assessing DCog Short for identifying neurotoxicity related to CAR-T therapy, with the study not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy
• Immune Effector Cell Associated Neurotoxicity Syndrome

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Neurotoxicity, Neurotoxicity Syndromes | NA | Status: NOT_YET_RECRUITING